Astera Labs, US04626A1034

Fubon starts coverage with USD 500 target for Astera Labs stock

Published on 10/06/2026 at 17:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 392.40 million, 104.50 percent above last year. Astera Labs stock stood at EUR 320.00 on October 5, 2026 after EUR 310.00.

Astera Labs, US04626A1034, Illustration mit AI erstellt.
Astera Labs, US04626A1034, Illustration mit AI erstellt.

Astera Labs stock (ISIN US04626A1034) is tied to a new USD 500.00 price target after Fubon initiated coverage with a Buy rating, as Investing.com reported on October 6, 2026. The note date was not specified in the report, so the target is best read as a current market reference rather than a dated earnings forecast.

S&P 500 hopes meet stronger revenue

The immediate catalyst is the expectation that Astera Labs could qualify for inclusion in the S&P 500 during a future quarterly rebalancing. The same Investing.com report placed the company among the leading candidates and cited its market capitalization as above the index eligibility threshold.

That index narrative has a fundamental counterweight. In the second quarter of 2026, revenue reached USD 392.40 million, up 104.50 percent from the prior-year quarter and above the USD 360.70 million consensus cited by Investing.com. Adjusted earnings per share came in at USD 0.80 versus USD 0.69 expected.

Targets now sit above the consensus

Fubon is not the only firm shaping expectations. MarketBeat listed a Moderate Buy consensus based on one Strong Buy, twelve Buy ratings and eight Hold ratings, with an average target of USD 348.33. Its review also recorded earlier targets of USD 325.00 from Barclays, USD 335.00 from Morgan Stanley and USD 450.00 from Roth Capital.

For the operating outlook, Astera Labs guided third-quarter 2026 revenue to USD 540 million to USD 560 million, with a 72.00 percent gross margin and a 43.00 percent operating margin, according to Investing.com. The range implies a substantial sequential step-up from second-quarter revenue, but the exact outcome depends on demand for its connectivity products.

Tradegate price gives the German view

Astera Labs identifies itself as a Nasdaq-listed provider of connectivity solutions for rack-scale AI infrastructure, combining PCIe, CXL, Ethernet and related technologies in its Intelligent Connectivity Platform, according to its Astera Labs investor-relations page. Nasdaq-listed ALAB was at USD 392.18 at 11:27 a.m. ET on October 6, 2026, while its market capitalization stood at USD 67.2 billion.

For German investors, the dated euro reference is separate from the Nasdaq quote. Astera Labs was last at EUR 320.00 on Tradegate on October 5, 2026 at 8:22 p.m. CEST, up 3.23 percent versus the Tradegate close of EUR 310.00. The contrast between a USD 500.00 Fubon target and the USD 348.33 average target shows how widely expectations have spread.

Astera Labs stock facts

  • Company: Astera Labs, Inc.
  • ISIN: US04626A1034
  • Ticker: ALAB
  • Primary exchange: NASDAQ
  • Price Tradegate as of October 5, 2026, 8:22 p.m. CEST: EUR 320.00
  • Change versus Tradegate close: plus 3.23 percent
  • Tradegate close October 5, 2026: EUR 310.00
  • Market capitalization: USD 67.2 billion as of October 6, 2026
  • Sector / Industry: Information technology / semiconductors
  • Index membership: NASDAQ 100

More news and analyses on Astera Labs stock

Disclaimer...

en | US04626A1034 | ASTERA LABS | boerse | 70243855 | bgmi